Literature DB >> 12211779

Live-donor renal transplantation at the Urology & Nephrology Center of Mansoura: 1976-1998.

M A Ghoneim1, M A Bakr, N Hassan, I Wahba, A S Fouda, M A Sobh, A B Shehab el-Dein, A A Shokeir, M M el-Mekresh, B Ali-el-Dein, Y M Osman, A Moustafa, F el-Chenawi.   

Abstract

Based on more than 1,200 living donor transplants performed at the Urology & Nephrology Center at Mansoura University between 1976-1998, we report: 1. The overall graft survival rate was 75.8% and 51.9% at 5 and 10 years, respectively, with a projected half-life of 10.7 years. 2. Three factors acted as independent variables that significantly influenced graft survival: the number of HLA mismatches, the number of acute rejection episodes and the presence of posttransplant hypertension. a. Grafts with 2 or fewer HLA-A, -B and -DR mismatches had a significantly better survival rate. b. The incidence and the number of early acute rejection episodes had a significant negative impact on graft survival. c. A significant reduction in graft survival was associated with hypertension uncontrolled by or newly developed after transplantation. 3. Bilharziasis had no impact on the outcome. 4. Despite improvements in tissue matching and immunosuppression, an important proportion of grafts is still lost following living-donor kidney transplantation. 5. Efforts must be directed to identify better regimens, which can provide adequate immunosuppression and minimal nephrotoxicity.

Entities:  

Mesh:

Year:  2001        PMID: 12211779

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


  2 in total

1.  Pediatric live-donor kidney transplantation in Mansoura Urology & Nephrology Center: a 28-year perspective.

Authors:  Amr A El-Husseini; Mohamed A Foda; Mohamed A Bakr; Ahmed A Shokeir; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

2.  Factors affecting graft survival among patients receiving kidneys from live donors: a single-center experience.

Authors:  Mohamed A Ghoneim; Mohamed A Bakr; Ayman F Refaie; Ahmed I Akl; Ahmed A Shokeir; Ahmed B Shehab El-Dein; Hesham M Ammar; Amani M Ismail; Hussein A Sheashaa; Mahmoud A El-Baz
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.